{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:05:26Z","timestamp":1794380726044,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["F31 NS084556"],"award-info":[{"award-number":["F31 NS084556"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13024-018-0270-8","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T07:47:39Z","timestamp":1533714459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases"],"prefix":"10.1186","volume":"13","author":[{"given":"Jason A.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejung","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alden Y.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wojta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Bensimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Nigel","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Payan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey","family":"Shatunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Deloukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Amouyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Tzourio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Dartigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M.","family":"Bronstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Al-Chalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-1061","authenticated-orcid":false,"given":"Giovanni","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"issue":"4","key":"270_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/mds.25327","volume":"28","author":"G Respondek","year":"2013","unstructured":"Respondek G, Roeber S, Kretzschmar H, Troakes C, Al-Sarraj S, Gelpi E, Gaig C, Chiu WZ, van Swieten JC, Oertel WH, et al. Accuracy of the national institute for neurological disorders and stroke\/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Mov Disord. 2013;28(4):504\u20139.","journal-title":"Mov Disord"},{"issue":"4","key":"270_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/jamaneurol.2014.4040","volume":"72","author":"JA Chen","year":"2015","unstructured":"Chen JA, Wang Q, Davis-Turak J, et al. A multiancestral genome-wide exome array study of alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy. JAMA Neurol. 2015;72(4):414\u201322.","journal-title":"JAMA Neurol"},{"issue":"6","key":"270_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain. 2005;128(6):1247\u201358.","journal-title":"Brain"},{"issue":"1","key":"270_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","volume":"66","author":"KA Josephs","year":"2006","unstructured":"Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell J, Duffy JR, Parisi JE, Dickson DW. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66(1):41\u20138.","journal-title":"Neurology"},{"issue":"2","key":"270_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/mds.10680","volume":"19","author":"Y Osaki","year":"2004","unstructured":"Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, Quinn N. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord. 2004;19(2):181\u20139.","journal-title":"Mov Disord"},{"issue":"7","key":"270_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S1474-4422(14)70088-2","volume":"13","author":"AL Boxer","year":"2014","unstructured":"Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, et al. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2\/3 trial. Lancet Neurol. 2014;13(7):676\u201385.","journal-title":"Lancet Neurol"},{"issue":"1","key":"270_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/brain\/awn291","volume":"132","author":"G Bensimon","year":"2009","unstructured":"Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain. 2009;132(1):156\u201371.","journal-title":"Brain"},{"issue":"7","key":"270_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","volume":"43","author":"GU Hoglinger","year":"2011","unstructured":"Hoglinger GU, Melhem NM, Dickson DW, Sleiman PMA, Wang L-S, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011;43(7):699\u2013705.","journal-title":"Nat Genet"},{"issue":"3","key":"270_CR9","doi-asserted-by":"publisher","first-page":"e1004211","DOI":"10.1371\/journal.pgen.1004211","volume":"10","author":"Y Li","year":"2014","unstructured":"Li Y, Chen JA, Sears RL, Gao F, Klein ED, Karydas A, Geschwind MD, Rosen HJ, Boxer AL, Guo W, et al. An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative Tauopathy. PLoS Genet. 2014;10(3):e1004211.","journal-title":"PLoS Genet"},{"issue":"D1","key":"270_CR10","doi-asserted-by":"publisher","first-page":"D670","DOI":"10.1093\/nar\/gku1177","volume":"43","author":"KR Rosenbloom","year":"2015","unstructured":"Rosenbloom KR, Armstrong J, Barber GP, Casper J, Clawson H, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L, Haeussler M, et al. The UCSC genome browser database: 2015 update. Nucleic Acids Res. 2015;43(D1):D670\u201381.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"270_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience. 2015;4(1):1\u201316.","journal-title":"GigaScience"},{"issue":"6","key":"270_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrg3472","volume":"14","author":"E Evangelou","year":"2013","unstructured":"Evangelou E, Ioannidis JPA. Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet. 2013;14(6):379\u201389.","journal-title":"Nat Rev Genet"},{"issue":"7311","key":"270_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature09298","volume":"467","author":"The International HapMap 3 Consortium","year":"2010","unstructured":"The International HapMap 3 Consortium. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467(7311):52\u20138.","journal-title":"Nature"},{"issue":"6","key":"270_CR14","doi-asserted-by":"publisher","first-page":"e1000529","DOI":"10.1371\/journal.pgen.1000529","volume":"5","author":"BN Howie","year":"2009","unstructured":"Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5(6):e1000529.","journal-title":"PLoS Genet"},{"issue":"4","key":"270_CR15","doi-asserted-by":"publisher","first-page":"e1004234","DOI":"10.1371\/journal.pgen.1004234","volume":"10","author":"J O'Connell","year":"2014","unstructured":"O'Connell J, Gurdasani D, Delaneau O, Pirastu N, Ulivi S, Cocca M, Traglia M, Huang J, Huffman JE, Rudan I, et al. A general approach for haplotype phasing across the full Spectrum of relatedness. PLoS Genet. 2014;10(4):e1004234.","journal-title":"PLoS Genet"},{"key":"270_CR16","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1038\/ncomms4934","volume":"5","author":"O Delaneau","year":"2014","unstructured":"Delaneau O, Marchini J. The genomes project C: integrating sequence and array data to create an improved 1000 genomes project haplotype reference panel. Nat Commun. 2014;5:3934.","journal-title":"Nat Commun"},{"issue":"3","key":"270_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/ng.3190","volume":"47","author":"P-R Loh","year":"2015","unstructured":"Loh P-R, Tucker G, Bulik-Sullivan BK, Vilhjalmsson BJ, Finucane HK, Salem RM, Chasman DI, Ridker PM, Neale BM, Berger B, et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat Genet. 2015;47(3):284\u201390.","journal-title":"Nat Genet"},{"issue":"1","key":"270_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/bioinformatics\/19.1.149","volume":"19","author":"S Purcell","year":"2003","unstructured":"Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19(1):149\u201350.","journal-title":"Bioinformatics"},{"key":"270_CR19","doi-asserted-by":"publisher","first-page":"005165","DOI":"10.1101\/005165","volume-title":"bioRxiv","author":"SD Turner","year":"2014","unstructured":"Turner SD. qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots. In: bioRxiv; 2014. p. 005165. \n                    https:\/\/doi.org\/10.1101\/005165\n                    \n                  ."},{"issue":"3","key":"270_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):48.","journal-title":"J Stat Softw"},{"issue":"4","key":"270_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ng1333","volume":"36","author":"ML Freedman","year":"2004","unstructured":"Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004;36(4):388\u201393.","journal-title":"Nat Genet"},{"issue":"15","key":"270_CR22","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1093\/hmg\/dds161","volume":"21","author":"G Coppola","year":"2012","unstructured":"Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet. 2012;21(15):3500\u201312.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"270_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/gepi.20579","volume":"35","author":"H-C So","year":"2011","unstructured":"So H-C, Gui AHS, Cherny SS, Sham PC. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol. 2011;35(5):310\u20137.","journal-title":"Genet Epidemiol"},{"issue":"9192","key":"270_CR24","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","volume":"354","author":"A Schrag","year":"1999","unstructured":"Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet. 1999;354(9192):1771\u20135.","journal-title":"Lancet"},{"issue":"7","key":"270_CR25","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/brain\/124.7.1438","volume":"124","author":"U Nath","year":"2001","unstructured":"Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ. The prevalence of progressive supranuclear palsy (Steele\u2013Richardson\u2013Olszewski syndrome) in the UK. Brain. 2001;124(7):1438\u201349.","journal-title":"Brain"},{"issue":"1","key":"270_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","volume":"88","author":"J Yang","year":"2011","unstructured":"Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88(1):76\u201382.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"270_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BWJH, Jansen R, de Geus EJC, Boomsma DI, Wright FA, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48(3):245\u201352.","journal-title":"Nat Genet"},{"issue":"2","key":"270_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1534\/genetics.114.167908","volume":"198","author":"F Hormozdiari","year":"2014","unstructured":"Hormozdiari F, Kostem E, Kang EY, Pasaniuc B, Eskin E. Identifying causal variants at loci with multiple signals of association. Genetics. 2014;198(2):497\u2013508.","journal-title":"Genetics"},{"issue":"7539","key":"270_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nature14222","volume":"518","author":"JR Dixon","year":"2015","unstructured":"Dixon JR, Jung I, Selvaraj S, Shen Y, Antosiewicz-Bourget JE, Lee AY, Ye Z, Kim A, Rajagopal N, Xie W, et al. Chromatin architecture reorganization during stem cell differentiation. Nature. 2015;518(7539):331\u20136.","journal-title":"Nature"},{"issue":"7398","key":"270_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11082","volume":"485","author":"JR Dixon","year":"2012","unstructured":"Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, Hu M, Liu JS, Ren B. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012;485(7398):376\u201380.","journal-title":"Nature"},{"issue":"7626","key":"270_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature19847","volume":"538","author":"H Won","year":"2016","unstructured":"Won H, de la Torre-Ubieta L, Stein JL, Parikshak NN, Huang J, Opland CK, Gandal MJ, Sutton GJ, Hormozdiari F, Lu D, et al. Chromosome conformation elucidates regulatory relationships in developing human brain. Nature. 2016;538(7626):523\u20137.","journal-title":"Nature"},{"issue":"3","key":"270_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.3211","volume":"47","author":"BK Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan BK, Loh P-R, Finucane HK, Ripke S, Yang J. Schizophrenia working Group of the Psychiatric Genomics C, Patterson N, Daly MJ, price AL, Neale BM: LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47(3):291\u20135.","journal-title":"Nat Genet"},{"issue":"7","key":"270_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ejhg.2011.39","volume":"19","author":"J Yang","year":"2011","unstructured":"Yang J, Weedon MN, Purcell S, Lettre G, Estrada K, Willer CJ, Smith AV, Ingelsson E, O'Connell JR, Mangino M, et al. Genomic inflation factors under polygenic inheritance. Eur J Hum Genet. 2011;19(7):807\u201312.","journal-title":"Eur J Hum Genet"},{"issue":"18","key":"270_CR34","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/hmg\/dds238","volume":"21","author":"D Trabzuni","year":"2012","unstructured":"Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, Smith C, Luk C, Gibbs JR, Dillman A, Hernandez DG, et al. MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet. 2012;21(18):4094\u2013103.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"270_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1212\/WNL.0000000000003615","volume":"88","author":"J Chen","year":"2017","unstructured":"Chen J, Yu J-T, Wojta K, Wang H-F, Zetterberg H, Blennow K, Yokoyama JS, Weiner MW, Kramer JH, Rosen H, et al. Genome-wide association study identifies MAPT locus influencing human plasma tau levels. Neurology. 2017;88(7):669\u201376.","journal-title":"Neurology"},{"issue":"1","key":"270_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00441-009-0832-8","volume":"339","author":"T Komori","year":"2009","unstructured":"Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 2009;339(1):189\u201395.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"270_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"270_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JSK, Younkin S, et al. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"5","key":"270_CR39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","volume":"68","author":"JO Johnson","year":"2010","unstructured":"Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, Gibbs JR, Brunetti M, Gronka S, Wuu J, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5):857\u201364.","journal-title":"Neuron"},{"issue":"4","key":"270_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng1332","volume":"36","author":"GDJ Watts","year":"2004","unstructured":"Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36(4):377\u201381.","journal-title":"Nat Genet"},{"issue":"11","key":"270_CR41","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00228-009-0714-8","volume":"65","author":"BL Urquhart","year":"2009","unstructured":"Urquhart BL, Kim RB. Blood\u2212brain barrier transporters and response to CNS-active drugs. Eur J Clin Pharmacol. 2009;65(11):1063\u201370.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"270_CR42","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.neuron.2015.08.020","volume":"87","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Tseng IC, Heyser Charles J, Rockenstein E, Mante M, Adame A, Zheng Q, Huang T, Wang X, Arslan Pharhad E, et al. Appoptosin-mediated caspase cleavage of tau contributes to progressive Supranuclear palsy pathogenesis. Neuron. 2015;87(5):963\u201375.","journal-title":"Neuron"},{"issue":"6","key":"270_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng.3289","volume":"47","author":"A Legati","year":"2015","unstructured":"Legati A, Giovannini D, Nicolas G, Lopez-Sanchez U, Quintans B, Oliveira JRM, Sears RL, Ramos EM, Spiteri E, Sobrido M-J, et al. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export. Nat Genet. 2015;47(6):579\u201381.","journal-title":"Nat Genet"},{"issue":"1","key":"270_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mds.26374","volume":"31","author":"MA Nalls","year":"2016","unstructured":"Nalls MA, Keller MF, Hernandez DG, Chen L, Stone DJ, Singleton AB. On behalf of the Parkinson\u2019s progression marker initiative i: baseline genetic associations in the Parkinson\u2019s progression markers initiative (PPMI). Mov Disord. 2016;31(1):79\u201385.","journal-title":"Mov Disord"},{"issue":"9","key":"270_CR45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng.3622","volume":"48","author":"W van Rheenen","year":"2016","unstructured":"van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RAA, Vosa U, de Jong S, Robinson MR, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1043\u20138.","journal-title":"Nat Genet"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0270-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-018-0270-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0270-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:10:30Z","timestamp":1565205030000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-018-0270-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["270"],"URL":"https:\/\/doi.org\/10.1186\/s13024-018-0270-8","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]},"assertion":[{"value":"16 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained for all patients participating in the Allon Therapeutics davunetide trial and the NNIPPS trial, and IRB approval was obtained from the corresponding Institutional Review Boards. For the NNIPPS study,\u00a0The protocol and amendments were reviewed and approved by the Comit\u00e9 de Protection des Personnes of Piti\u00e9-Salp\u00eatri\u00e8re Hospital (France), the UK Multicentre Research Ethics Committee (MREC) (UK), Ethikkommission of the University of Ulm (Germany) and by local Institutional Review Boards (Ethics Committees) where appropriate (UK, Germany). For the BBBIPPS study, the protocol and amendments were reviewed and approved by the Comit\u00e9 de Protection des Personnes of Piti\u00e9-Salp\u00eatri\u00e8re Hospital (France).\u00a0Additional data was obtained via NIAGADS and dbGAP in accordance with data access policies. The Institutional Review Board at the University of California, Los Angeles, approved the joint study design, including review of outside consent forms.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.A.C. is founder of Verge Genomics, a biotechnology company, and holds an equity stake. P.A. is a member of the Scientific Advisory Board of Genoscreen, a biotechnology company, and Director of the Fondation Plan Alzheimer, a non-profit organization. J-F.G. has received research grant funding from Roche.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"41"}}